메뉴 건너뛰기




Volumn , Issue 43, 2011, Pages 75-78

Tissue and soluble biomarkers in breast cancer and their applications: Ready to use?

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; BIOLOGICAL MARKER; CA 15-3 ANTIGEN; CA 27-29 ANTIGEN; CYTOKERATIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL CELL ADHESION MOLECULE; EPITHELIAL CELL ADHESION MOLECULE 1; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN P53; TRASTUZUMAB; UNCLASSIFIED DRUG; UROKINASE; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; CD146 ANTIGEN; CELL ADHESION MOLECULE; EPCAM PROTEIN, HUMAN; MCAM PROTEIN, HUMAN; PROGESTERONE RECEPTOR; SERPINE1 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

EID: 84855183439     PISSN: 10526773     EISSN: 17456614     Source Type: Book Series    
DOI: 10.1093/jncimonographs/lgr023     Document Type: Article
Times cited : (10)

References (25)
  • 1
    • 67650380136 scopus 로고    scopus 로고
    • Biomarkers of response and resistance to antiangiogenic therapy
    • Jain RK, Duda DG, Willett CG, et al. Biomarkers of response and resistance to antiangiogenic therapy. Nat Rev Clin Oncol. 2009, 6(6): 327-338.
    • (2009) Nat Rev Clin Oncol , vol.6 , Issue.6 , pp. 327-338
    • Jain, R.K.1    Duda, D.G.2    Willett, C.G.3
  • 2
    • 75549085009 scopus 로고    scopus 로고
    • Circulating tumor-derived predictive biomarkers in oncology
    • Hodgson DR, Wellings E, Orr M, et al. Circulating tumor-derived predictive biomarkers in oncology. Drug Discov Today. 2010, 15(3-4): 98-101.
    • (2010) Drug Discov Today , vol.15 , Issue.3-4 , pp. 98-101
    • Hodgson, D.R.1    Wellings, E.2    Orr, M.3
  • 3
    • 78149472680 scopus 로고    scopus 로고
    • Optimizing the management of HER2-positive early breast cancer: the clinical reality
    • Verma S, Lavasani S, Mackey J, et al. Optimizing the management of HER2-positive early breast cancer: the clinical reality. Curr Oncol. 2010, 17(4): 20-33.
    • (2010) Curr Oncol , vol.17 , Issue.4 , pp. 20-33
    • Verma, S.1    Lavasani, S.2    Mackey, J.3
  • 4
    • 36849069347 scopus 로고    scopus 로고
    • American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
    • Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007, 25(33): 5287-5312.
    • (2007) J Clin Oncol , vol.25 , Issue.33 , pp. 5287-5312
    • Harris, L.1    Fritsche, H.2    Mennel, R.3
  • 5
    • 78649825336 scopus 로고    scopus 로고
    • Current and emerging biomarkers in breast cancer: prognosis and prediction [published online ahead of print July 10 2010]
    • Weigel MT, Dowsett M. Current and emerging biomarkers in breast cancer: prognosis and prediction [published online ahead of print July 10, 2010]. Endocr Relat Cancer. 2010, 17(4): 245-262.
    • (2010) Endocr Relat Cancer , vol.17 , Issue.4 , pp. 245-262
    • Weigel, M.T.1    Dowsett, M.2
  • 6
    • 77955715822 scopus 로고    scopus 로고
    • A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer
    • Colleoni M, Bagnardi V, Rotmensz N, et al. A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer. Eur J Cancer. 2010, 46(12): 2216-2224.
    • (2010) Eur J Cancer , vol.46 , Issue.12 , pp. 2216-2224
    • Colleoni, M.1    Bagnardi, V.2    Rotmensz, N.3
  • 7
    • 33748693297 scopus 로고    scopus 로고
    • Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
    • Buyse M, Loi S, van't Veer L, et al. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst. 2006, 98(17): 1183-1192.
    • (2006) J Natl Cancer Inst , vol.98 , Issue.17 , pp. 1183-1192
    • Buyse, M.1    Loi, S.2    van't Veer, L.3
  • 8
    • 34250652449 scopus 로고    scopus 로고
    • Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
    • Desmedt C, Piette F, Loi S, et al. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res. 2007, 13(11): 3207-3214.
    • (2007) Clin Cancer Res , vol.13 , Issue.11 , pp. 3207-3214
    • Desmedt, C.1    Piette, F.2    Loi, S.3
  • 9
    • 55749109051 scopus 로고    scopus 로고
    • Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
    • Nolen BM, Marks JR, Ta'san S, et al. Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer. Breast Cancer Res. 2008, 10(3): R45.
    • (2008) Breast Cancer Res , vol.10 , Issue.3
    • Nolen, B.M.1    Marks, J.R.2    Ta'san, S.3
  • 10
    • 4143094988 scopus 로고    scopus 로고
    • Circulating tumor cells, disease progression and survival in metastatic breast cancer
    • Cristofanilli M, Budd T, Ellis MJ, et al. Circulating tumor cells, disease progression and survival in metastatic breast cancer. N Engl J Med. 2004, 351(8): 781-791.
    • (2004) N Engl J Med , vol.351 , Issue.8 , pp. 781-791
    • Cristofanilli, M.1    Budd, T.2    Ellis, M.J.3
  • 11
    • 76749130731 scopus 로고    scopus 로고
    • Circulating tumor cells as a prognostic marker in metastatic breast cancer
    • Andreopoulou E, Cristofanilli M. Circulating tumor cells as a prognostic marker in metastatic breast cancer. Expert Rev Anticancer Ther. 2010, 10(2): 171-177.
    • (2010) Expert Rev Anticancer Ther , vol.10 , Issue.2 , pp. 171-177
    • Andreopoulou, E.1    Cristofanilli, M.2
  • 12
    • 77649237594 scopus 로고    scopus 로고
    • Circulating tumor cells in clinical practice: methods of detection and possible characterization
    • Alunni-Fabbroni M, Sandri MT. Circulating tumor cells in clinical practice: methods of detection and possible characterization. Methods. 2010, 50(4): 289-297.
    • (2010) Methods , vol.50 , Issue.4 , pp. 289-297
    • Alunni-Fabbroni, M.1    Sandri, M.T.2
  • 13
    • 58549113573 scopus 로고    scopus 로고
    • Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells
    • Sieuwerts AM, Kraan J, Bolt J, et al. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst. 2009, 101(1): 61-66.
    • (2009) J Natl Cancer Inst , vol.101 , Issue.1 , pp. 61-66
    • Sieuwerts, A.M.1    Kraan, J.2    Bolt, J.3
  • 14
    • 79954689654 scopus 로고    scopus 로고
    • Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146 [published online ahead of print April 9 2010]
    • Mostert B, Kraan J, Bolt-de Vries J, et al. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146 [published online ahead of print April 9, 2010]. Breast Cancer Res Treat. 2011, 127(1): 33-41.
    • (2011) Breast Cancer Res Treat , vol.127 , Issue.1 , pp. 33-41
    • Mostert, B.1    Kraan, J.2    Bolt-de Vries, J.3
  • 15
    • 78649613643 scopus 로고    scopus 로고
    • Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients
    • Obermayr E, Sanchex-Cabo F, Tea MK, et al. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients. BMC Cancer. 2010, 3(10): 666.
    • (2010) BMC Cancer , vol.3 , Issue.10 , pp. 666
    • Obermayr, E.1    Sanchex-Cabo, F.2    Tea, M.K.3
  • 16
    • 70249150745 scopus 로고    scopus 로고
    • Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer
    • De Giorgi U, Valero V, Rohren E, et al. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. J Clin Oncol. 2009, 27(20): 3303-3311.
    • (2009) J Clin Oncol , vol.27 , Issue.20 , pp. 3303-3311
    • De Giorgi, U.1    Valero, V.2    Rohren, E.3
  • 17
    • 57049162148 scopus 로고    scopus 로고
    • Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial
    • Pierga JY, Bidard FC, Mathior C, et al. Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial. Clin Cancer Res. 2008, 14(21): 7004-7010.
    • (2008) Clin Cancer Res , vol.14 , Issue.21 , pp. 7004-7010
    • Pierga, J.Y.1    Bidard, F.C.2    Mathior, C.3
  • 18
    • 77953007231 scopus 로고    scopus 로고
    • Circulating tumor cells in the management of breast cancer
    • Nagaiah G, Abraham J. Circulating tumor cells in the management of breast cancer. Clin Breast Cancer. 2010, 10(3): 209-216.
    • (2010) Clin Breast Cancer , vol.10 , Issue.3 , pp. 209-216
    • Nagaiah, G.1    Abraham, J.2
  • 19
    • 55549115023 scopus 로고    scopus 로고
    • Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?
    • Dawood S, Broglio K, Valero V, et al. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system? Cancer. 2008, 113(9): 2422-2430.
    • (2008) Cancer , vol.113 , Issue.9 , pp. 2422-2430
    • Dawood, S.1    Broglio, K.2    Valero, V.3
  • 20
    • 77956132705 scopus 로고    scopus 로고
    • Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy [published online ahead of print March 16 2010]
    • Bidard FC, Mathiot C, Degeorges A, et al. Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy [published online ahead of print March 16, 2010]. Ann Oncol. 2010, 21(9): 1765-1771.
    • (2010) Ann Oncol , vol.21 , Issue.9 , pp. 1765-1771
    • Bidard, F.C.1    Mathiot, C.2    Degeorges, A.3
  • 21
    • 0034082024 scopus 로고    scopus 로고
    • Detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer
    • Sorenson GD. Detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer. Clin Cancer Res. 2000, 6(6): 2129-2137.
    • (2000) Clin Cancer Res , vol.6 , Issue.6 , pp. 2129-2137
    • Sorenson, G.D.1
  • 22
    • 77449135297 scopus 로고    scopus 로고
    • Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer
    • Schwarzenbach H, Pantel K, Kemper B, et al. Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer. Breast Cancer Res. 2009, 11(5): R71.
    • (2009) Breast Cancer Res , vol.11 , Issue.5
    • Schwarzenbach, H.1    Pantel, K.2    Kemper, B.3
  • 23
    • 77958557955 scopus 로고    scopus 로고
    • Molecular biomarker analyses using circulating tumor cells
    • Punnoose EA, Atwal SK, Spoerke JM, et al. Molecular biomarker analyses using circulating tumor cells. PLoS One. 2010, 5(9): e12517.
    • (2010) PLoS One , vol.5 , Issue.9
    • Punnoose, E.A.1    Atwal, S.K.2    Spoerke, J.M.3
  • 24
    • 77952120469 scopus 로고    scopus 로고
    • Improving the yield of circulating tumour cells facilitates molecular characterization and recognition of discordant HER2 amplification in breast cancer
    • Flores LM, Kindelberger DW, Ligon AH, et al. Improving the yield of circulating tumour cells facilitates molecular characterization and recognition of discordant HER2 amplification in breast cancer. Br J Cancer. 2010, 102(10): 1495-1502.
    • (2010) Br J Cancer , vol.102 , Issue.10 , pp. 1495-1502
    • Flores, L.M.1    Kindelberger, D.W.2    Ligon, A.H.3
  • 25
    • 77958486873 scopus 로고    scopus 로고
    • Circulating tumor cells and emerging blood biomarkers in breast cancer [published online ahead of print August 11 2010]
    • Criscitiello C, Sotirou C, Ignatiadis M. Circulating tumor cells and emerging blood biomarkers in breast cancer [published online ahead of print August 11, 2010]. Curr Opin Oncol. 2010, 22(6): 552-558.
    • (2010) Curr Opin Oncol , vol.22 , Issue.6 , pp. 552-558
    • Criscitiello, C.1    Sotirou, C.2    Ignatiadis, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.